Mondor's disease;Morbus mondor

Hautarzt

Volumn 54, Issue 10, 2003, Pages 990-992

  Mang, R ^a   Assmann, T ^a   Megahed, M ^a   Ruzicka, T ^a   Stege, H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; IBUPROFEN;

ADULT; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE PREDISPOSITION; DOPPLER ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MONDOR SYNDROME; RISK FACTOR; SKIN INFLAMMATION;

EID: 0141920501     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-003-0599-x     Document Type: Conference Paper

References (8)

1. Abramson DJ (1966) Mondor's disease and string phlebitis. JAMA 196:1087-1089
2. Bejanga BI (1992) Mondor's disease: analysis of 30 cases. J R Coll Surg Edinb 37:322-432
3. Catania S, Zurrida S, Veronesi P et al. (1992) Mondor's disease and breast cancer. Cancer 69:2267-2270
4. Holle-Robatsch S, Fink AM, Schubert C et al. (2001) Mondor phlebitis in Assoziation mit Hepatitis C. Vasa 30:297-298
5. Marsch WC, Haas N, Stuttgen G (1986) "Mondor's phlebitis" - a lymphovascular process. Light and electron microscopic indications. Dermatologica 172:133-138
6. Mayor M, Buron I, de Mora JC et al. (2000) Mondor's disease. Int J Dermatol 39:922-925
7. Mondor H.(1939) Tronculite sous-cutanée subaigue de la paroi thoracique antéro-latérale. Mem Acad Chir 65:1271-1278
8. Pugh CM, DeWitty RL (1996) Mondor's disease. J Natl Med Assoc 88:359-363